Effects of diabetes on myocardial infarct size and cardioprotection by preconditioning and postconditioning
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Effects of diabetes on myocardial infarct size and cardioprotection by preconditioning and postconditioning
Authors
Keywords
-
Journal
Cardiovascular Diabetology
Volume 11, Issue 1, Pages 67
Publisher
Springer Nature
Online
2012-06-21
DOI
10.1186/1475-2840-11-67
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Hyperglycemia raises the threshold of levosimendan- but not milrinone-induced postconditioning in rat hearts
- (2012) Shuhei Matsumoto et al. Cardiovascular Diabetology
- High-dose fasudil preserves postconditioning against myocardial infarction under hyperglycemia in rats: role of mitochondrial KATP channels
- (2012) Taiga Ichinomiya et al. Cardiovascular Diabetology
- Cardiovascular Biology of the Incretin System
- (2012) John R. Ussher et al. ENDOCRINE REVIEWS
- Pathophysiology of myocardial reperfusion injury: preconditioning, postconditioning, and translational aspects of protective measures
- (2011) Shoji Sanada et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- Diabetes Blockade of Sevoflurane Postconditioning Is Not Restored by Insulin in the Rat Heart
- (2011) Benjamin Drenger et al. ANESTHESIOLOGY
- The potential effects of anti-diabetic medications on myocardial ischemia–reperfusion injury
- (2011) Yumei Ye et al. BASIC RESEARCH IN CARDIOLOGY
- Early and late effects of the DPP-4 inhibitor vildagliptin in a rat model of post-myocardial infarction heart failure
- (2011) Meimei Yin et al. Cardiovascular Diabetology
- Efficacy of Cardioprotective ‘Conditioning’ Strategies in Aging and Diabetic Cohorts
- (2011) Karin Przyklenk DRUGS & AGING
- Ischaemic postconditioning revisited: lack of effects on infarct size following primary percutaneous coronary intervention
- (2011) X. Freixa et al. EUROPEAN HEART JOURNAL
- Mortality and cardiovascular risk associated with different insulin secretagogues compared with metformin in type 2 diabetes, with or without a previous myocardial infarction: a nationwide study
- (2011) Tina Ken Schramm et al. EUROPEAN HEART JOURNAL
- Intravenous Erythropoietin in Patients With ST-Segment Elevation Myocardial Infarction
- (2011) Samer S. Najjar JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Type 2 diabetic obese db/db mice are refractory to myocardial ischaemic post-conditioning in vivo: potential role for Hsp20, F1-ATPase δ and Echs1
- (2011) Shu-Guang Zhu et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2·7 million participants
- (2011) Goodarz Danaei et al. LANCET
- Cardioprotection with Postconditioning: Loss of Efficacy in Murine Models of Type-2 and Type-1 Diabetes
- (2010) Karin Przyklenk et al. ANTIOXIDANTS & REDOX SIGNALING
- Diabetes mellitus abrogates erythropoietin-induced cardioprotection against ischemic-reperfusion injury by alteration of the RISK/GSK-3β signaling
- (2010) Nehmat Ghaboura et al. BASIC RESEARCH IN CARDIOLOGY
- A pore way to die: the role of mitochondria in reperfusion injury and cardioprotection
- (2010) Andrew P. Halestrap BIOCHEMICAL SOCIETY TRANSACTIONS
- Effects of oral glucose-lowering drugs on long term outcomes in patients with diabetes mellitus following myocardial infarction not treated with emergent percutaneous coronary intervention - a retrospective nationwide cohort study
- (2010) Casper H Jørgensen et al. Cardiovascular Diabetology
- Pre-treatment with a DPP-4 Inhibitor is Infarct Sparing in Hearts from Obese, Pre-diabetic Rats
- (2010) Barbara Huisamen et al. CARDIOVASCULAR DRUGS AND THERAPY
- Postconditioning and protection from reperfusion injury: where do we stand? * Position Paper from the Working Group of Cellular Biology of the Heart of the European Society of Cardiology
- (2010) M. Ovize et al. CARDIOVASCULAR RESEARCH
- Single-Dose Intravenous Administration of Recombinant Human Erythropoietin Is a Promising Treatment for Patients With Acute Myocardial Infarction
- (2010) Takuya Ozawa et al. CIRCULATION JOURNAL
- Comparison of two sulfonylureas with high and low myocardial KATP channel affinity on myocardial infarct size and metabolism in a rat model of type 2 diabetes
- (2010) S. B. Kristiansen et al. DIABETOLOGIA
- A single dose of erythropoietin in ST-elevation myocardial infarction
- (2010) A. A. Voors et al. EUROPEAN HEART JOURNAL
- The inter-relationship of diabetes and left ventricular systolic function on outcome after high-risk myocardial infarction
- (2010) Amil M. Shah et al. EUROPEAN JOURNAL OF HEART FAILURE
- The effect of intravenous administration of erythropoietin on the infarct size in primary percutaneous coronary intervention
- (2010) Jung-Won Suh et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Effect of Cyclosporine on Left Ventricular Remodeling After Reperfused Myocardial Infarction
- (2010) Nathan Mewton et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Pharmacological Preconditioning in Type 2 Diabetic Rat Hearts: The Roles of Mitochondrial ATP-Sensitive Potassium Channels and the Phosphatidylinositol 3-Kinase-Akt Pathway
- (2009) Shuhei Matsumoto et al. CARDIOVASCULAR DRUGS AND THERAPY
- Short Communication: Angiotensin II Type 1 Receptor–Mediated Upregulation of Calcineurin Activity Underlies Impairment of Cardioprotective Signaling in Diabetic Hearts
- (2009) Hiroyuki Hotta et al. CIRCULATION RESEARCH
- Endoplasmic Reticulum Stress in Diabetic Hearts Abolishes Erythropoietin-Induced Myocardial Protection by Impairment of Phospho–Glycogen Synthase Kinase-3β–Mediated Suppression of Mitochondrial Permeability Transition
- (2009) Takayuki Miki et al. DIABETES
- High-dose erythropoietin in patients with acute myocardial infarction: A pilot, randomised, placebo-controlled study
- (2009) Maurizio Ferrario et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Glimepiride Treatment Upon Reperfusion Limits Infarct Size via the Phosphatidylinositol 3-Kinase/Akt Pathway in Rabbit Hearts
- (2009) Hirofumi Nishida et al. JOURNAL OF PHARMACOLOGICAL SCIENCES
- Myocardial ischemic postconditioning against ischemia-reperfusion is impaired in ob/ob mice
- (2008) Omar Bouhidel et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- Limitation of myocardial infarct size in the clinical setting: current status and challenges in translating animal experiments into clinical therapy
- (2008) Tetsuji Miura et al. BASIC RESEARCH IN CARDIOLOGY
- Pioglitazone, a peroxisome proliferator-activated receptor-γ agonist, attenuates myocardial ischemia–reperfusion injury in mice with metabolic disorders
- (2008) Tsuyoshi Honda et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- Paclitaxel-Eluting Coronary Stents in Patients With Diabetes Mellitus
- (2008) Ajay J. Kirtane et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation